Shares of Ekf Diagnostics Holding PLC (LON:EKF) shot up 5.9% during trading on Friday . The stock traded as high as GBX 34.03 ($0.44) and last traded at GBX 34 ($0.44). 252,812 shares changed hands during mid-day trading, an increase of 22% from the average session volume of 206,806 shares. The stock had previously closed at GBX 32.10 ($0.42).
In other Ekf Diagnostics news, insider Christopher H. B. Mills sold 491,493 shares of the stock in a transaction on Tuesday, November 20th. The stock was sold at an average price of GBX 27 ($0.35), for a total transaction of £132,703.11 ($173,400.12).
About Ekf Diagnostics (LON:EKF)
EKF Diagnostics Holdings plc designs, develops, manufactures, and sells diagnostic instruments, reagents, and other ancillary products in the Americas, Europe, the Middle East, Africa, and internationally. It offers DiaSpect Tm, an hemoglobin analyzer; DiaSpect Hemoglobin T Low to determine low levels of hemoglobin in plasma and serum specimens, aqueous solutions, or stored or banked erythrocytes; Hemo Control, a point-of-care hemoglobin analyzer that provides quantitative and lab quality hemoglobin results; and HemataStat II, a centrifuge that provides a hematocrit reading for six blood samples.
Featured Article: 12b-1 Fees